From: Driving developments in UK oesophageal radiotherapy through the SCOPE trials
Development | Use prior to respective trials | Use currently | Comments |
---|---|---|---|
Consensus protocol for target volume delineation | Not specifically assessed in questionnaire | 100% | Prior to SCOPE 1 trial there was wide variation in practice across the UK [14] |
Use of prospective dose constraints | Not specifically assessed in questionnaire | 96% | In 88% of centres these are based on the corresponding SCOPE trial |
3d conformal planning | 29% | 100% | Now replaced by IMRT in SCOPE 2 |
Stomach filling protocol | 12.5% | 50% | Â |
CBCT | 66.7% | 87.5% | Â |
4D CT | 42% | 71% | Â |
Use of type b algorithm | 79.9% | 83.3% | pre NeoSCOPEa |
IMRT | 75% [1] | 79% | [1]12.5% only using for upper 1/3 pre SCOPE 2 |